Safety and Feasibility of Umbilical Cord Blood Cell Transplant Into Injured Spinal Cord
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
To investigate the feasibility, safety, efficacy and optimal dose of umbilical cord blood
mononuclear cell transplant in the treatment of chronic spinal cord injuries.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
China Spinal Cord Injury Network
Collaborators:
Chinese University of Hong Kong The University of Hong Kong